Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Volitionrx Ltd 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 USA

www.volition.com Employees: 110 P: 646-650-1351

Description:

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types. The Company's development activities are primarily centered in Belgium. Volition RX Ltd is based in Singapore.

Key Statistics

Overview:

Market Capitalization, $K 62,632
Enterprise Value, $K 46,732
Shares Outstanding, K 92,665
Annual Sales, $ 780 K
Annual Net Income, $ -35,320 K
Last Quarter Sales, $ 470 K
Last Quarter Net Income, $ -5,820 K
EBIT, $ -29,980 K
EBITDA, $ -28,830 K
60-Month Beta 1.17
% of Insider Shareholders 12.80%
% of Institutional Shareholders 8.09%
Float, K 80,804
% Float 87.20%
Short Volume Ratio 0.28

Growth:

1-Year Return 2.39%
3-Year Return -79.14%
5-Year Return -85.31%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 12.28%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/14/24
Next Earnings Date N/A
Earnings Per Share ttm -0.36
EPS Growth vs. Prev Qtr 12.50%
EPS Growth vs. Prev Year 36.36%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VNRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -163.39%
Profit Margin % -4,528.21%
Debt/Equity -0.21
Price/Sales 69.47
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.25
Interest Coverage -161.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar